4.6 Article

Adenoviral delivery of VHL suppresses bone sarcoma cell growth through inhibition of Wnt/β-catenin signaling

Related references

Note: Only part of the references are listed.
Review Oncology

VHL, the story of a tumour suppressor gene

Lucy Gossage et al.

NATURE REVIEWS CANCER (2015)

Article Biochemistry & Molecular Biology

GSK3β negatively regulates HIF1α mRNA stability via nucleolin in the MG63 osteosarcoma cell line

Dong-dong Cheng et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Review Pharmacology & Pharmacy

Targeted therapies in bone sarcomas: current approach and future directions

Jessica Lee Yarber et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)

Article Orthopedics

Reduced Expression of von Hippel-Lindau Protein Correlates with Decreased Apoptosis and High Chondrosarcoma Grade

Changbao Chen et al.

JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2011)

Article Biochemistry & Molecular Biology

Recombinant human PDCD5 sensitizes chondrosarcomas to cisplatin chemotherapy in vitro and in vivo

Changbao Chen et al.

APOPTOSIS (2010)

Review Cell Biology

Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases

Bryan T. MacDonald et al.

DEVELOPMENTAL CELL (2009)

Article Biochemistry & Molecular Biology

VHL loss of function and its impact on oncogenic signaling networks in clear cell renal cell carcinoma

W. Marston Linehan et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)

Article Biochemistry & Molecular Biology

β-catenin gets jaded and von Hippel-Lindau is to blame

Jason D. Berndt et al.

TRENDS IN BIOCHEMICAL SCIENCES (2009)

Review Immunology

WNT signalling in the immune system: WNT is spreading its wings

Frank J. T. Staal et al.

NATURE REVIEWS IMMUNOLOGY (2008)

Review Medicine, General & Internal

Sarcoma

Keith M. Skubitz et al.

MAYO CLINIC PROCEEDINGS (2007)

Article Cell Biology

Interaction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia

Abderrahmane Kaidi et al.

NATURE CELL BIOLOGY (2007)

Article Biochemistry & Molecular Biology

Osteosarcoma and chondrosarcoma: New signaling pathways as targets for novel therapeutic interventions

Dionysios J. Papachristou et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)

Article Multidisciplinary Sciences

The !von Hippel-Lindau tumor suppressor gene product represses oncogenic β-catenin signaling in renal carcinoma cells

Benedetta Peruzzi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Biochemistry & Molecular Biology

Priming-dependent phosphorylation and regulation of the tumor suppressor pVHL by glycogen synthase kinase 3

Alexander Hergovich et al.

MOLECULAR AND CELLULAR BIOLOGY (2006)

Article Biochemistry & Molecular Biology

Interplay between VHL/HIF1α and Wnt/β-catenin pathways during colorectal tumorigenesis

R. H. Giles et al.

ONCOGENE (2006)

Article Biochemistry & Molecular Biology

p53 stabilization and transactivation by a von Hippel-Lindau protein

Jae-Seok Roe et al.

MOLECULAR CELL (2006)

Review Genetics & Heredity

WNT and β-catenin signalling:: Diseases and therapies

RT Moon et al.

NATURE REVIEWS GENETICS (2004)

Review Oncology

Hypoxia - A key regulatory factor in tumour growth

AL Harris

NATURE REVIEWS CANCER (2002)

Article Biochemistry & Molecular Biology

The von Hippel-Lindau gene product inhibits renal cell apoptosis via Bcl-2-dependent pathways

P Devarajan et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)

Review Neurosciences

The multifaceted roles of glycogen synthase kinase 3β in cellular signaling

CA Grimes et al.

PROGRESS IN NEUROBIOLOGY (2001)